BIOVF Statistics

Total Valuation

BIOVF has a market cap or net worth of 12.54 billion. The enterprise value is 13.87 billion.

Market Cap	12.54B
Enterprise Value	13.87B

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	344.66M
Shares Outstanding	n/a
Shares Change (YoY)	-1.02%
Shares Change (QoQ)	-0.73%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	48.22%
Float	220.73M

Valuation Ratios

The trailing PE ratio is 9,086.81 and the forward PE ratio is 18.49.

PE Ratio	9,086.81
Forward PE	18.49
PS Ratio	4.24
PB Ratio	3.28
P/TBV Ratio	n/a
P/FCF Ratio	16.11
P/OCF Ratio	16.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.20, with an EV/FCF ratio of 17.82.

EV / Earnings	10,053.06
EV / Sales	4.69
EV / EBITDA	12.20
EV / EBIT	18.31
EV / FCF	17.82

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.38.

Current Ratio	1.02
Quick Ratio	0.69
Debt / Equity	0.38
Debt / EBITDA	1.27
Debt / FCF	1.85
Interest Coverage	8.01

Financial Efficiency

Return on equity (ROE) is 0.01% and return on invested capital (ROIC) is 8.53%.

Return on Equity (ROE)	0.01%
Return on Assets (ROA)	6.41%
Return on Invested Capital (ROIC)	8.53%
Return on Capital Employed (ROCE)	13.47%
Revenue Per Employee	1.56M
Profits Per Employee	730
Employee Count	1,806
Asset Turnover	0.40
Inventory Turnover	1.41

Taxes

Income Tax	-74.82M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.16% in the last 52 weeks. The beta is 0.19, so BIOVF's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+26.16%
50-Day Moving Average	29.18
200-Day Moving Average	23.63
Relative Strength Index (RSI)	65.17
Average Volume (20 Days)	507

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIOVF had revenue of 2.96 billion and earned 1.38 million in profits. Earnings per share was 0.00.

Revenue	2.96B
Gross Profit	2.31B
Operating Income	757.21M
Pretax Income	-74.29M
Net Income	1.38M
EBITDA	1.12B
EBIT	757.21M
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 110.26 million in cash and 1.44 billion in debt, giving a net cash position of -1.33 billion.

Cash & Cash Equivalents	110.26M
Total Debt	1.44B
Net Cash	-1.33B
Net Cash Per Share	n/a
Equity (Book Value)	3.82B
Book Value Per Share	11.08
Working Capital	26.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 783.31 million and capital expenditures -4.99 million, giving a free cash flow of 778.32 million.

Operating Cash Flow	783.31M
Capital Expenditures	-4.99M
Free Cash Flow	778.32M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 78.16%, with operating and profit margins of 25.62% and 0.05%.

Gross Margin	78.16%
Operating Margin	25.62%
Pretax Margin	-2.51%
Profit Margin	0.05%
EBITDA Margin	37.98%
EBIT Margin	25.62%
FCF Margin	26.33%

Dividends & Yields

BIOVF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.02%
Shareholder Yield	1.02%
Earnings Yield	0.01%
FCF Yield	6.21%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIOVF has an Altman Z-Score of 3.21 and a Piotroski F-Score of 7.

Altman Z-Score	3.21
Piotroski F-Score	7